What is the recommended treatment for AF patients undergoing PCI/stenting and presenting with an ACS and low bleeding risk (HAS-BLED 0-2)?
We suggest triple therapy for 6 months, followed by dual therapy with OAC plus single antiplatelet (preferably clopidogrel) until 12 months, following which OAC monotherapy can be used (Weak recommendation, low quality evidence).